Digest Network Come funziona
Network
/
Società
Ba
Non verificato

Bayer

Di cosa scriviamo

BiotecnologiaFarmaceuticaIndustriaMedicina - VarieSalute

47 comunicati stampa

Guarda tutti i comunicati
04/04/2025
Legge/Diritto
Biotecnologia
Associazioni/Professionisti
Sanità
Salute
Farmaceutica
Bevande
Agricoltura
Materie prime
Pubblico Esercizio/Vendita al dettaglio
Bayer announces filing of petition to U.S. Supreme Court for review of Durnell Roundup™ case
Fonte
Bayer
Emittente
Business Wire
1,00
0
25/03/2025
Analisi di mercato
Industria
Scienza
Sanità
Medicina nucleare
Farmaceutica
Oncologia
Fitness
Biotecnologia
Salute
Comprehensive Review of More Than 400 Studies Conducted Over 30 Years:
Fonte
Bayer
Emittente
Business Wire
1,00
0
25/03/2025
Fiere
Industria
Scienza
Cardiologia
Farmaceutica
Salute
Igiene alimentare
Medicina - Varie
ACC.25: Bayer Presents New Investigational Heart Failure Data and Continued Portfolio Research in Chronic Kidney Disease in Type 2 Diabetes
Fonte
Bayer
Emittente
Business Wire
1,00
0
24/03/2025
Mercato del lavoro
Scienza
Agricoltura
Materie prime
Farmaceutica
Salute
Fitness
Dr. Mike Graham Appointed as New Head of R&D for Bayer’s Crop Science Division
Fonte
Bayer
Emittente
Business Wire
1,00
0
17/03/2025
Industria
Scienza
Igiene alimentare
Salute
Medicina - Varie
Cardiologia
Biotecnologia
Farmaceutica
U.S. FDA Accepts Supplemental New Drug Application Under Priority Review for New Indication for KERENDIA® (finerenone) in Patients with Heart Failure with Left Ventricular Ejection Fraction of ≥40%
Fonte
Bayer
Emittente
Business Wire
1,00
0
03/03/2025
Bayer Introduces Vyconic™ Soybeans, a Groundbreaking Advance in Weed Management, at Commodity Classic 2025
Fonte
Bayer
Emittente
Business Wire
1,00
0
26/02/2025
Oncologia
Salute
Medicina nucleare
Medicina - Varie
Farmaceutica
Biotecnologia
Industria
Late-breaking data from QUANTI CNS (Central Nervous System) presented at ECR 2025:
Fonte
Bayer
Emittente
Business Wire
1,00
0
18/02/2025
Bayer® Aspirin Continues Longstanding Commitment to Heart Health Education, Encouraging Americans to “See Their Risks”
Fonte
Bayer
Emittente
Business Wire
1,00
0
13/02/2025
Biotecnologia
Farmaceutica
Salute
Oncologia
Industria
New Data for NUBEQA® Build on Safety and Efficacy Results Across Subgroups of Patients with Metastatic Hormone-Sensitive Prostate Cancer
Fonte
Bayer
Emittente
Business Wire
1,00
0
09/10/2024
Industria
Biotecnologia
Farmaceutica
Sanità
Salute
Igiene alimentare
Vetrine/Shopping
Medicina - Varie
U.S. Food and Drug Administration (FDA) accepts New Drug Application for elinzanetant
Fonte
Bayer
Emittente
Business Wire
1,00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0